🇵🇹 Daily Portugal news for expats & investors — FREE Subscribe

Latest

Montenegro Files 'Trabalhar — Fazer Portugal Maior' Third Strategic Motion for the 43rd PSD Congress in Anadia on 20-21 June — Sole Candidate, Slogan Borrowed From Cavaco Silva, 'Não É Não' to Chega and No Bloco Central With PS

Montenegro Files 'Trabalhar — Fazer Portugal Maior' Third Strategic Motion for the 43rd PSD Congress in Anadia on 20-21 June — Sole Candidate, Slogan Borrowed From Cavaco Silva, 'Não É Não' to Chega and No Bloco Central With PS

Montenegro filed his third strategic motion before Monday's PSD deadline, double the 1,500-signature threshold. 'Trabalhar — Fazer Portugal Maior' marries a Cavaco-era slogan to a renewed 'não é não' to Chega and no central bloc with PS. 43rd Congress in Anadia 20-21 June.
The Portugal Brief
Corticeira Amorim Cuts a Further 212 Posts Across 2025 With Amorim Cork Solutions Carrying 126 of the Layoffs — Workforce Closes the Year at 4,637 Versus 4,999 in 2022 and Personnel Costs Drop €2.5 Million Despite Higher Average Pay

Corticeira Amorim Cuts a Further 212 Posts Across 2025 With Amorim Cork Solutions Carrying 126 of the Layoffs — Workforce Closes the Year at 4,637 Versus 4,999 in 2022 and Personnel Costs Drop €2.5 Million Despite Higher Average Pay

Corticeira Amorim's 2025 Relatório e Contas books a 212-post net headcount cut, with the Cork Solutions division absorbing 126 as Silves consolidates into Vendas Novas on a €3M one-off. Workforce closes at 4,637 (vs 4,999 in 2022); personnel costs -€2.5M on higher average pay.
The Portugal Brief
Infarmed Reads SNS Medicine Spend at a Record €4.417 Billion in 2025 — Hospital Drugs Cross €2.5 Billion for the First Time as Oncology Adds €864.5 Million at +16% and Ambulatory Comparticipação Lifts to €1.894 Billion at +12.4%

Infarmed Reads SNS Medicine Spend at a Record €4.417 Billion in 2025 — Hospital Drugs Cross €2.5 Billion for the First Time as Oncology Adds €864.5 Million at +16% and Ambulatory Comparticipação Lifts to €1.894 Billion at +12.4%

Infarmed's 2025 monitor puts SNS medicine spending at a record €4,417M — +60% above the 2020 baseline. Hospitals carry €2,523M (+11.2%), ambulatory €1,894M (+12.4%), families €966M (+4.9%). Oncology adds €864.5M (+16%), orphan drugs +34.1%, and Q1 2026 hospitals already +7.6%.
The Portugal Brief